FIELD: biotechnology.
SUBSTANCE: invention relates to application of a formula (III) ligand for preparation of conjugates of oligonucleotides and compositions based thereon, which can be used in medicine
(III).
A new effective ligand of formula (III) is provided for preparation of a conjugate in which the ligand for the asialoglycoprotein receptor is attached to an antisense oligonucleotide or siRNA via an amide bond to deliver the said antisense oligonucleotide or siRNA to the cell, respectively. A method for preparation of such a conjugate comprises conjugating a formula (III) ligand and an oligonucleotide or siRNA with NHC-6 hexylaminolinker at the 5'-end of the sense strand and O-acetate groups removal.
EFFECT: increased compound efficiency.
3 cl, 6 dwg, 18 tbl, 52 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2011 |
|
RU2582235C2 |
| COMPOSITION OF DELIVERY SYSTEM BASED ON CONJUGATE FOR RNA-INTERFERENCE POLYNUCLEOTIDE DELIVERY TO LIVER CELL AND PROCESS FOR ITS PREPARATION | 2011 |
|
RU2623160C9 |
| NEW CRYSTAL FORM OF VASCULAR PERMEABILITY BLOCKER COMPOUND | 2020 |
|
RU2809162C2 |
| CONJUGATES FOR INTEGRIN ANTAGONIST TARGETED DELIVERY TO CELLS, EXPRESSING LFA-1 | 2013 |
|
RU2624731C2 |
| NEW AZETIDINE DERIVATIVES | 2013 |
|
RU2629114C2 |
| CONJUGATES FOR DELIVERY OF POLYNUCLEOTIDES IN VIVO, CONTAINING BONDS SENSITIVE TO ENZYMATIC DEGRADATION | 2011 |
|
RU2619453C2 |
| NEW BRAF INHIBITORS AS "PARADOX BREAKERS" | 2020 |
|
RU2825870C1 |
| NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING IT, AS WELL AS METHOD FOR THEIR PRODUCTION AND USE | 2018 |
|
RU2782211C2 |
| CONJUGATES FOR INTEGRIN ANTAGONIST TARGETED DELIVERY TO CELLS, EXPRESSING LFA-1 | 2013 |
|
RU2624732C2 |
| TRANSGLUTAMINASE 2 (TG2) INHIBITORS | 2019 |
|
RU2781370C2 |
